RNXT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

RenovoRx Inc

NASDAQ | RNXT

1.17

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$47.27M

Market Cap

-

P/E Ratio

-0.38

EPS

$1.69

52 Week High

$0.75

52 Week Low

HEALTHCARE

Sector

RNXT Chart

Recent Chart
Price Action

RNXT Technicals

Tags:

RNXT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $43K
Total Revenue $43K
Cost Of Revenue $0
Costof Goods And Services Sold $0
Operating Income -$11M
Selling General And Administrative $5M
Research And Development $6M
Operating Expenses $11M
Investment Income Net -
Net Interest Income $384K
Interest Income -
Interest Expense $384K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$8.8M
Income Tax Expense -$8.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$8.8M
Comprehensive Income Net Of Tax -
Ebit -$11M
Ebitda -$11M
Net Income -$8.8M

Revenue & Profitability

Earnings Performance

RNXT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $8.1M
Total Current Assets $7.8M
Cash And Cash Equivalents At Carrying Value $7.2M
Cash And Short Term Investments $7.2M
Inventory -
Current Net Receivables $43K
Total Non Current Assets $290K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $631K
Other Non Current Assets -
Total Liabilities $3.6M
Total Current Liabilities $1.9M
Current Accounts Payable $586K
Deferred Revenue -
Current Debt -
Short Term Debt $132K
Total Non Current Liabilities $1.7M
Capital Lease Obligations $278K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $278K
Other Current Liabilities $1.2M
Other Non Current Liabilities -
Total Shareholder Equity $4.5M
Treasury Stock -
Retained Earnings -$50M
Common Stock $2K
Common Stock Shares Outstanding $24M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$9.1M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $12K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$12K
Cashflow From Financing $15M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8.8M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $43K
Total Revenue $43K
Cost Of Revenue $0
Costof Goods And Services Sold $0
Operating Income -$11M
Selling General And Administrative $5M
Research And Development $6M
Operating Expenses $11M
Investment Income Net -
Net Interest Income $384K
Interest Income -
Interest Expense $384K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$8.8M
Income Tax Expense -$8.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$8.8M
Comprehensive Income Net Of Tax -
Ebit -$11M
Ebitda -$11M
Net Income -$8.8M

RNXT News

RNXT Profile

RenovoRx Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

RenovoRx, Inc. is a clinical-stage biopharmaceutical company based in Los Altos, California, dedicated to innovating targeted therapies for solid tumors. The company's lead product candidates utilize proprietary delivery systems to maximize the local concentration of therapeutic agents while minimizing systemic exposure, addressing significant unmet needs in oncology. With a robust pipeline and commitment to improving patient outcomes through advanced therapeutic solutions, RenovoRx is positioned to make a substantial impact in the field of cancer treatment.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.12%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
INTC
+4.26%
$37.15
WHWK
+24.28%
$2.61
KVUE
-13.34%
$14.09
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
GDXD
-10.20%
$0.60
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
QBTS
-9.62%
$40.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
SNAP
-1.83%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
JBLU
-3.63%
$4.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
WULF
-9.53%
$13.99
JOBY
-8.66%
$16.07
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.12%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
INTC
+4.26%
$37.15
WHWK
+24.28%
$2.61
KVUE
-13.34%
$14.09
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
GDXD
-10.20%
$0.60
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
QBTS
-9.62%
$40.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
SNAP
-1.83%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
JBLU
-3.63%
$4.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
WULF
-9.53%
$13.99
JOBY
-8.66%
$16.07
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.